Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.57
Delayed Data
As of 12:33pm ET
 -0.0099 / -0.63%
Today’s Change
1.42
Today|||52-Week Range
4.84
-22.27%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 19.50 and a low estimate of 6.00. The median estimate represents a +727.97% increase from the last price of 1.57.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Rexahn Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.13
Sales
$0.00
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.04%
 
 
 
 
 
 
Growthannually 38.04%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.